SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (3658)9/19/1997 12:02:00 PM
From: Sonki   of 3991
 
we wont' sell vvus til gets 54....

TA, what do u think of this? is good to invest in both?

Zonagen has developed an
anti-impotence pill, Vasomex, that is expected to challenge rival treatments because it restores "a man's natural ability to achieve an
erection--without resorting to artificial means;" company expected to file with the FDA soon and is currently engaged in talks with major
drugmaker to distribute Vasomex worldwide; new drug faces competitive challenge from Pfizer's Viagra drug which is also an oral treatment.
briefing.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext